B+
Bull case
20%
Probability
Target price
$37.80
+55.1% vs current
Market commentary is mixed-to-cautious: analyst consensus sits near the low- to mid-30s with a wide low/high spread, indicating differing views on adoption and execution [#SERP-1]. Recent coverage highlights upward target revisions at the high end while some outlets emphasize downside risk to utilization and reimbursement [#SERP-4] [#SERP-9]. Overall tone is balanced but sensitive to near-term execution and policy signals.
No evidence quality warning is currently attached to this memo.
No formal recommendation provided.